相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 供应商:
齐源
- 库存:
999
- 靶点:
CD274
- 级别:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 目录编号:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 克隆性:
单克隆
- 抗原来源:
大鼠
- 保质期:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 抗体英文名:
Brilliant Violet 711™ anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 抗体名:
CD274 (B7-H1, PD-L1) 抗体
- 标记物:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 宿主:
大鼠
- 适应物种:
小鼠
- 免疫原:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 亚型:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 形态:
anti-mouse CD274 (B7-H1, PD-L1) Antibody
- 应用范围:
FC
- 保存条件:
2-8℃
- 浓度:
0.2 mg/ml
- 规格:
50 ug
Brilliant Violet 711™ anti-mouse CD274 (B7-H1, PD-L1) Antibody详细如下:
Description :CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type Itransmembrane protein and a member of the B7 family within the immunoglobulin receptorsuperfamily. It is expressed on T cells, B cells, NK cells, dendritic cells, IFN-γ activatedendothelial cells, and monocytes. B7-H1 is one of the ligands of PD-1. The interaction of B7-H1with PD-1 plays an important role in the inhibition of T cell responses. Other studies haveshown that B7-H1 is able to costimulate T cell growth and cytokine production. CD274 isinvolved in costimulation essential for T cell proliferation and production of IL-10 and IFN-γ, inan IL-2-dependent and a PD-1-independent manner. Its interaction with PD-1 inhibits T cellproliferation and cytokine production.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Rat
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation :The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 711™under optimal conditions.
Concentration :0.2 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cellsin 100 µl volume. It is recommended that the reagent be titrated for optimal performance for eachapplication.
Brilliant Violet 711™ excites at 405 nm and emits at 711 nm. The bandpass filter 710/50 nm isrecommended for detection, although filter optimization may be required depending on otherfluorophores used. Be sure to verify that your cytometer configuration and software setupare appropriate for detecting this channel. Refer to your instrument manual or manufacturerfor support. Brilliant Violet 711™ is a trademark of Sirigen Group Ltd.
Excitation Laser :Violet Laser (405 nm)
Description :CD274, also known as B7-H1 or programmed death ligand 1 (PD-L1), is a 40 kD type Itransmembrane protein and a member of the B7 family within the immunoglobulin receptorsuperfamily. It is expressed on T cells, B cells, NK cells, dendritic cells, IFN-γ activatedendothelial cells, and monocytes. B7-H1 is one of the ligands of PD-1. The interaction of B7-H1with PD-1 plays an important role in the inhibition of T cell responses. Other studies haveshown that B7-H1 is able to costimulate T cell growth and cytokine production. CD274 isinvolved in costimulation essential for T cell proliferation and production of IL-10 and IFN-γ, inan IL-2-dependent and a PD-1-independent manner. Its interaction with PD-1 inhibits T cellproliferation and cytokine production.
Verified Reactivity :Mouse
Antibody Type :Monoclonal
Host Species :Rat
Formulation :Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
Preparation :The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 711™under optimal conditions.
Concentration :0.2 mg/ml
Storage & Handling :The antibody solution should be stored undiluted between 2°C and 8°C, and protected fromprolonged exposure to light. Do not freeze.
Application :FC - Quality tested
Recommended Usage :Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometricanalysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 µg per million cellsin 100 µl volume. It is recommended that the reagent be titrated for optimal performance for eachapplication.
Brilliant Violet 711™ excites at 405 nm and emits at 711 nm. The bandpass filter 710/50 nm isrecommended for detection, although filter optimization may be required depending on otherfluorophores used. Be sure to verify that your cytometer configuration and software setupare appropriate for detecting this channel. Refer to your instrument manual or manufacturerfor support. Brilliant Violet 711™ is a trademark of Sirigen Group Ltd.
Excitation Laser :Violet Laser (405 nm)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Application References(PubMed link indicatesBioLegend citation):
1. Maier H, et al. 2007. J. Immunol. 178:2714.
2. Meng Q, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:4444. PubMed
3. Scarlett UK, et al. 2012. J Exp Med. 209:495. PubMed
4. Grabie N, et al. 2007. Circulation 116:2062. (IF, IHC)
5. Paterson AM, et al. 2011. J. Immunol. 187:1097.
6. Channappanavar R, et al. 2012. PLoS One 7:e39757. (Block)
7. Schreiber HA, et al. 2010. PLoS One 5:e11453. (Block) PubMed
8. Muthumani K, et al. 2011. J. Immunol. 187:2932. (Block) PubMed
9. Cripps JG, et al. 2010. Hepatology 52:1350. (Block) PubMed
10. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
11. Riella LV, et al. 2011. Am. J. Transplant 11:832-40. (IHC)
12. Lei GS, et al. 2015. Infect Immun. 83:572. PubMed
Product Citations:
1. Bruand M, et al. 2021. Cell Reports. 36(3):109412. PubMed
2. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
3. Stathopoulou C, et al. 2020. Immunity. 49(2):247-263.e7.. PubMed
4. Dong L, et al. 2021. Cancer Cell. . PubMed
5. Pingili AK, et al. 2021. Cell Reports. 35(12):109285. PubMed
6. DeLong JH, et al. 2019. Immunohorizons. 3:13. PubMed
7. Shi L, et al. 2016. Nat Commun. 7:12335. PubMed
8. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
9. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
1. Maier H, et al. 2007. J. Immunol. 178:2714.
2. Meng Q, et al. 2006. Invest. Ophthalmol. Vis. Sci. 47:4444. PubMed
3. Scarlett UK, et al. 2012. J Exp Med. 209:495. PubMed
4. Grabie N, et al. 2007. Circulation 116:2062. (IF, IHC)
5. Paterson AM, et al. 2011. J. Immunol. 187:1097.
6. Channappanavar R, et al. 2012. PLoS One 7:e39757. (Block)
7. Schreiber HA, et al. 2010. PLoS One 5:e11453. (Block) PubMed
8. Muthumani K, et al. 2011. J. Immunol. 187:2932. (Block) PubMed
9. Cripps JG, et al. 2010. Hepatology 52:1350. (Block) PubMed
10. Murakami R, et al. 2013. PLoS One. 8:73270. PubMed
11. Riella LV, et al. 2011. Am. J. Transplant 11:832-40. (IHC)
12. Lei GS, et al. 2015. Infect Immun. 83:572. PubMed
Product Citations:
1. Bruand M, et al. 2021. Cell Reports. 36(3):109412. PubMed
2. Lin C, et al. 2020. Cancer Immunol Res. 632:8. PubMed
3. Stathopoulou C, et al. 2020. Immunity. 49(2):247-263.e7.. PubMed
4. Dong L, et al. 2021. Cancer Cell. . PubMed
5. Pingili AK, et al. 2021. Cell Reports. 35(12):109285. PubMed
6. DeLong JH, et al. 2019. Immunohorizons. 3:13. PubMed
7. Shi L, et al. 2016. Nat Commun. 7:12335. PubMed
8. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
9. Gangoso E, et al. 2021. Cell. 184:2454. PubMed
文献支持
Brilliant Violet 711™ 抗小鼠 CD274 (B7-H1, PD-L1) 抗体
¥5200










